Research Article
Assessment of the Cytotoxic Activity of Triphala: A Semisolid Traditional Formulation on HepG2 Cancer Cell Line
Table 4
IC50 level of ethanolic extract of Triphala and its components and Cisplatin on HepG2 cells.
| ||||||||||||||||||||
All determinations were done in triplicate, the standard deviation for 95% confidence. aIC50: the concentration of drug required for 50% inhibition. bReference standard. |